Article Sidebar

pdf
Date Published: 16/09/2025
Abstract Views: 134
Views pdf: 95
DOI: https://doi.org/10.51298/vmj.v553i2.15376
Issue
Vol. 553 No. 2 (2025)
Section
Các bài báo
How to Cite
Ngô Thanh, T., & Nguyễn Mạnh, Q. (2025). A CASE REPORT WITH LARGE THROMBUS BURDEN IN ACUTE CORONARY PERCUTANEOUS INTERVENTION: SHOULD WE STOP OR CONTINUE?. Vietnam Medical Journal, 553(2). https://doi.org/10.51298/vmj.v553i2.15376

A CASE REPORT WITH LARGE THROMBUS BURDEN IN ACUTE CORONARY PERCUTANEOUS INTERVENTION: SHOULD WE STOP OR CONTINUE?

Tùng Ngô Thanh, Quân Nguyễn Mạnh

Main Article Content

Abstract

Background: A large thrombus burden is really common in acute coronary artery syndrome, especially in patients with STEMI. Primary percutaneous coronary revascularization is the current standard of care in patients with ACS. Despite the availability of potent P2Y12 antiplatelet agents, effective anticoagulants, and GP IIb/IIIa inhibitors, large intracoronary thrombus remains one of the biggest challenges to interventional cardiologists during primary PCI. Large thrombus burden can cause distal embolization, no/slow-reflow phenomenon, or embolization into a non-culprit vessel and is associated with adverse cardiovascular outcomes. There is no ideal management strategy. Therefore, we propose treatment options when we deal with this situation. Method: A case report. Result: We report a young, male patient who presented with ACS and had a large thrombus burden. The patient had performed PCI successfully. Conclusion: Large thrombus burden is a big challenge in cardiovascular intervention. There is no ideal management strategy, and we need personalized treatment. 

Article Details

Keywords

Acute coronary syndrome, large thrombus burden, thrombectomy

References

1. Alak A, Lugomirski P, Aleksova N, Jolly SS. A Meta-Analysis of Randomized Controlled Trials of Conventional Stenting Versus Direct Stenting in Patients With Acute Myocardial Infarction.J Invasive Cardiol. 2015;27(9):405-409.
2. Cassese S, Belle L, Ndrepepa G, et al. Deferred vs Immediate Stenting in Primary Percutaneous Coronary Intervention: A Collaborative Meta-analysis of Randomized Trials With Cardiac Magnetic Resonance Imaging Data. Can J Cardiol. 2018;34(12):1573-1580. doi:10. 1016/j.cjca.2018.07.480
3. Dai W, Ye Z, Li L, Su Q. Effect of preoperative loading dose ticagrelor and clopidogrel on no-reflow phenomenon during intervention in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis. Drug Des Devel Ther. 2018;12:2039-2049. doi:10.2147/DDDT.S165431.
4. Gibson CM, de Lemos JA, Murphy SA, et al. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation. 2001;103(21): 2550-2554. doi:10. 1161/01.cir.103.21.2550.
5. Greco C, Pelliccia F, Tanzilli G, et al. Usefulness of local delivery of thrombolytics before thrombectomy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (DISSOLUTION randomized trial). Am J Cardiol. 2013;112(5): 630-635. doi:10.1016/j.amjcard. 2013.04.036
6. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.Eur Heart J. 2018;39(2): 119-177. doi:10.1093/eurheartj/ehx393.
7. Magdy AM, Demitry SR, Hasan-Ali H, Zaky M, Abd El-Hady M, Abdel Ghany M. Stenting deferral in primary percutaneous coronary intervention: exploring benefits and suitable interval in heavy thrombus burden.Egypt Heart J. 2021;73(1):78. doi:10.1186/s43044-021-00203-3.
8. McCartney PJ, Eteiba H, Maznyczka AM, et al. Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial Infarction.JAMA. 2019; 321(1): 56-68. doi:10.1001/jama.2018. 19802.